Endo to Report First Quarter 2025 Financial Results on May 7, 2025

07.04.25 22:30 Uhr

Werte in diesem Artikel
Aktien

22,03 USD -0,22 USD -0,99%

MALVERN, Pa., April 7, 2025 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company") announced today that it will report first quarter 2025 financial results on May 7, 2025, prior to market open. The Company will host a conference call on the same day at 8:30 a.m. ET.

Endo logo

The audio webcast may be accessed through the Investor Relations section of the Company's website at investor.endo.com under Events & Presentations. To access the call through a conference line, participants may dial 800-836-8184 (U.S. and Canada toll-free) or 646-357-8785 (outside the U.S.). Participants are advised to join 10 minutes prior to the scheduled start time. A replay of the webcast will be available following the event.

About Endo
Endo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies. Our passionate team members collaborate to develop and deliver these essential medicines. Together, we are committed to helping everyone we serve live their best life. Learn more at www.endo.com or connect with us on LinkedIn.

Logo - https://mma.prnewswire.com/media/2621082/Endo_logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/endo-to-report-first-quarter-2025-financial-results-on-may-7-2025-302421528.html

In eigener Sache

Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Endo

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Endo

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Endo Inc Registered Shs

Wer­bung